Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Mga view
administrator
07/14/23
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento